Nexteligent Holdings Inc (NXGT)

[urge2surge]

Material event 3 day issuance of notice. Not sure how it'll be received to be honest. The revenues best justify the price tag. Looks speculative and sketchy by my take. Where's the 4.5 cash coming from? Merger partnership, equity line financing? Without seeing the books I can only speculate but from my take they best be peddling some contraband recreational products..

[BIOCHEMUP]

Wow haven’t read the financials, this IMS Experts looks like an acquisition upcoming for 2022 of which we just now received the first details?

[urge2surge]

So call me a wet blanket on a coldnight but....really? You've got to be kidding right? How and why?

https://www.imsexpertsretail.com/

[urge2surge]

Here's an excerpt that I found interesting. By what capacity given the financials?

As of this Q2 2022 filing, Nexteligent has now finalized and signed its Asset Purchase Agreement for Innovative
Medical Solutions Experts (“IMS”), a national distributor of Durable Medical Equipment headquartered in Texas.
Under the terms of the Asset Purchase Agreement (“APA”), Nexteligent is paying (i) cash of $5,200,000 of which
$4,200,000 is paid at the closing of the transaction and the balance is being paid in the form of a promissory note
of two annual installments on the anniversary date of the APA of $500,000 each and bearing simple interest of 6%
per annum and (ii) 1,800,000 shares of Series C preferred stock which is non-voting and converts at a conversion
price equal to the 30-day average closing price of Nexteligent’s common stock prior to the date of the conversion
request. The current executives of IMS, Craig Welch and Parker Welch, will join as President and CEO and Director
of Operations, respectively, of Nexteligent’s new wholly owned subsidiary, to be named IMS Experts, Inc

[EmptyBones]

Once them big sellers at .027 are gone it will fly..

[BIOCHEMUP]

Nexteligent remains committed to initiating its stock buyback program in concert with completion of its 2022
acquisitions.

Great news EmpyBones. QX uplist also still on the table.

[EmptyBones]

SS no change and no dilution.. Q/R report filed. Pink current. QX uplist with share buyback from company soon.

https://www.otcmarkets.com/otcapi/company/financial-report/342250/content

Investor Relations and Communications
• Nexteligent announced in August of 2021 that it had entered into an agreement with 2Watchmen to manage and
execute Nexteligent’s stock buyback initiative. The Company has terminated its relationship with 2Watchmen for
performance reasons.
• Nexteligent remains committed to initiating its stock buyback program in concert with completion of its 2022
acquisitions.
• The Company also remains committed to up listing to the OTCQX and as previously noted Nexteligent will be
working with PCAOB auditor MahoneySabol to complete its audit process, a listing requirement for joining the
OTCQX.
• Nexteligent Executive Management have decades of experience at Fortune 500 companies including MasterCard
International, Aon, Marsh & McLennan, Centene, Willis, and more. Our intent for communications is to emulate
the best practices of esteemed companies. We are committed to disseminating press releases and announcements
that will be meaningful to our shareholders as well as our employees, clients, and investors

[urge2surge]

I think so too. That's why I took a position. It's anyone's call on what's next. They may issue additional share buy backs or announce a RM. Either way, the only thing that matters is what they do. Everything else is hyperbole.

[BIOCHEMUP]

Nice post, either way very rare to see for an OTC stock what’s happening in the background.

[urge2surge]

The buy up on the notes were a solid indicator, and the financials didn't work with the propoganda buys they projected. It would require massive dilution, and the financial metrics wouldn't be attracted to revenue generating business's either. You don't add to restricted shares if you plan on diluting. Plain and simple. What's the hold up? Anyone's guess at this point. The ask stack waiting on short cover is a daily treat. Mms Ran it up, shorted, and cover. Classic price fixing controls..

[BIOCHEMUP]

It’s also viable that they maintain the shell (eliminating debentures, insider increase, …) while seeking new business opportunities as they arise. I do agree tho, intrinsically the shell has all the characteristics for a pending R/M. Whenever that might be.

[urge2surge]

The only viable play here is a Reverse Merger. Everything else is noise.

[BIOCHEMUP]

Yeah true but fact remains these acquisitions late 2021 no word repped about them this year makes you wonder if they fell through. Odds are high they did.

[urge2surge]

There's a lot of OMG the sky is falling clamor eh? Updates on share structures are transparent. Speculation is warranted, but emotional and declarative statements of absolute, smells of fear driven agendas. Anybody that wanted out is out and long gone. Unless somebody has inside information or a functional crystal ball, save the drama for mama..

[EmptyBones]

Share structure has Not changed. Stay tuned for some big updates coming.

Authorized Shares
100,000,000
08/04/2022
Outstanding Shares
73,937,469
08/04/2022
Restricted
36,406,813
08/04/2022
Unrestricted
37,530,656
08/04/2022

[BIOCHEMUP]

Still closed at 0.027 lol.

[Johnstown]

NXGT .02 and these dickwads keep dumping shares, smh

[BIOCHEMUP]

New financials 08/15?

[EmptyBones]

Because Market makers cross trading to get shares. There is zero paper getting sold and there will be none for a long time..

[urge2surge]

Well to be honest there's a lack of credibility warranted here. The only virtue, albeit bullish, was the buyback or subsequent note purchase, increasing the restricted and inside percentage. The communications on corporate developments and general communications in regards to shareholder value are beyond the pale. They do have tight share structures, and a legitimate candidate for a RM. Given the financials, their objective to acquire businesses to achieve a 100 million revenue, was and is a massive stretch of imaginations. To put it nicely. The RM continues to be the best play on untapping value imo.

Here's the rest of the press release. Pay attention to the M and A part.

"Nexteligent continues to execute its strategy for building a distinguished brand recognized for delivering value to employees, clients and investors," said Paul Cristiano, Nexteligent chief executive officer. "Within the last 60 days, we have announced our plan to close three acquisitions before year-end 2021 and that in 2022 we intend to close acquisitions with a collective revenue of $100,000,000."

Cristiano also noted that Nexteligent recently announced that it has retained a leading M&A advisory and investment firm to assist in its acquisition process as well as a PCAOB auditor and counsel organization to assist in its plans for up listing to the OTCQX and to concurrently address and rectify any vagaries in convertible notes and service contracts discovered through the audit process required for admission to the OTCQX.

[urge2surge]

That's one possibility as I posted after share update showed no change. The other is naked shorting or passing the bag by the MMS. Meaning, they coordinated a share drop to themselves in order to affect additional share sells by other retailers. Yeah, that crap happens in the markets. Aka price fixing. I don't think they got any of size fwiw, at least not not from me. They've also been stacking the ask. My suspicions are that a reversal is near. They're in the right sector as the health and bio small caps have been getting money flows. The OTC continues to be intentionally depressed. The OTC market as a whole is under a lock and key with this administration.
Here's a link to a spot on assessment of conditions in the OTC.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169455516

[BIOCHEMUP]

But the OS didn’t increase either? So wouldn’t that mean it could be retail all along?

[FIREMEDIC0001]

Very interesting...and makes sense...if this is true could restore some faith in this company that they are actually doing what they said they would do...let's hope that's the case

[urge2surge]

Something that's been puzzling me since the last share sell off, why the restricted didn't increase? Found this on the press release regarding the buyback. Looks like they've filled their allotted share goal.

NEW YORK, Aug. 30, 2021 /PRNewswire/ -- Nexteligent Holdings, Inc. (OTC:NXGT), a professional services firm and healthcare industry aggregator, has retained 2 Watchmen, a Wyoming limited liability company to assist in its proposed common stock buy-back program. Through this initiative, Nexteligent intends to repurchase from $100,000 to $1,000,000 in Company common stock at market price starting in September.

https://www.otcmarkets.com/stock/NXGT/news/Nexteligent-Retains-2-Watchmen-for-its-Stock-Buy-Back-Initiative?id=318613

[BIOCHEMUP]

Quite the spread in bid and ask. NXGT = mystery play in 2022.

[FIREMEDIC0001]

Would love to see an update from the company here

[Fat Thor]

Yep

[EmptyBones]

Share structure for 3 months remains the same. Obvious no note holders selling.. Share structure is perfect for uplist to QX or Nasdaq... Patience will pay off in todays market..

[BIOCHEMUP]

No developments, no upward pressure.

[urge2surge]

I said it could be a note that dropped. That's been the previous drops on volume. I waited to see the shares updated before concluding that it wasn't a note. I also said that it was retail selling or a bear raid. Both are plausible however I am of the opinion that it's retail selling.
As for corporate, the only bullish indicator has been the note purchases. There's no other quality of value from corporate to note.
On a personal note, you seem to have personal issues especially when anyone has a difference of opinion here. Feel free to use the ignore feature on my profile.
Hope that helps.

[SpacMan]

$0.01's again... Gee who could have predicted this.

[SpacMan]

Though u said a note dropped? Now its a bear raid or retail selling hey? lol You have no clue whats going on and neither does anyone else because this company never tells us anything, probably because they arn't doing anything worth saying.

[urge2surge]

Bear raid or retail sale yesterday. No changes on share structures.
https://www.otcmarkets.com/stock/NXGT/security

[urge2surge]

No shares updated today. Suspecting note purchase in progress.

[urge2surge]

Suspecting another note dropped. Also expecting restricted to increase in conjunction with outstanding as previous disbursements.

https://www.otcmarkets.com/stock/NXGT/security

[SpacMan]

Aka they have nothing worth press releasing still a year after announcing their plans. Cool. Same ole copy + paste reply.

[BIOCHEMUP]

Ask is thin all the way to 9cc. :o

[BIOCHEMUP]

Got a fast reply from Sanzaro asking for an update.

Good Morning.

The June 2022 filing will be submitted on time and contain any additional updates.
We are on track with our growth strategy, as outlined in our filings.

In addition, when material activities present themselves, NXGT will respond quickly.

Thanks.

[BIOCHEMUP]

Interesting graph, clearly something going wrong in the USA healthcare wise:



https://www.nexteligent.com/sector-challenges/

If they can solve these sector challenges as listed on the website, this stock will be a big winner in due time.

Financial discipline seems to be definitely present while we wait judging by the SS, convertible, rise of restricted shares, no unnecessary acquisitions.

[BIOCHEMUP]

Sellers gone. Nice how we are basing around $0,027.

[BIOCHEMUP]

Fingers crossed.

[urge2surge]

8 months since last press release. Trading activity picking up. Maybe July will garner news. Small caps and OTC garnering money inflows.

[EmptyBones]

yes.. Also updated Share structure has not changed at all...

[BIOCHEMUP]

Someone is accumulating at this price.

[urge2surge]

Also looks like controlled covering as well. Once that's covered it should pop. I thought we'd get a turn a few weeks back but without news the chart has continued consolidating. Despite the corporate silences, we're still in a favorable share structures. The additional notes and shares were also very bullish.

[BIOCHEMUP]

Everything on management terms here but looks like price is stabilized at this level.

[jump1]

It looks like it is almost go time.

Authorized Shares
100,000,000
07/01/2022
Outstanding Shares
73,937,469

[BIOCHEMUP]

Last financial updated on OTCMarket: 05/15.

[urge2surge]

What is the date of record? You might be right with the additional shares brought back into the authorized? Insider holdings are very bullish. Percentage wise the largest I've seen on the OTC.

[BIOCHEMUP]

Yeah my number is based on the financials, under company insiders: